Brave Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Brave Asset Management’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-500	Closed	-$6K	–	391
2016 Q3	$6K	Hold	500	–	–	﹤0.01%	351
2016 Q2	$6K	Hold	500	–	–	﹤0.01%	363
2016 Q1	$5K	Sell	500 -46,050	-99%	-$541K	﹤0.01%	385
2015 Q4	$1.05M	Sell	46,550 -100	-0.2%	-$2.05K	0.71%	38
2015 Q3	$774K	Buy	46,650 +25,500	+121%	+$511K	0.59%	47
2015 Q2	$476K	Hold	21,150	–	–	0.33%	81
2015 Q1	$545K	Buy	21,150 +3,800	+22%	+$96.4K	0.38%	75
2014 Q4	$378K	Buy	17,350 +12,100	+230%	+$248K	0.27%	93
2014 Q3	$99K	Buy	+5,250	New	+$106K	0.07%	172

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brave Asset Management's OMED Position: Q4 2016 in Review

Brave Asset Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q4 2016, closing a stake of 500 shares — an estimated $6K sold.

Brave Asset Management first reported a position in OMED in Q3 2014 and held it in 9 quarters. The position peaked at $1.05M in Q4 2015. 86 funds tracked by Wall St. Rank hold OMED as of Q4 2016.

Brave Asset Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Brave Asset Management sold 500 OncoMed Pharmaceuticals, Inc. shares in Q4 2016, an estimated $6K.
Brave Asset Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2014 and held it in 9 quarters.
Brave Asset Management's OncoMed Pharmaceuticals, Inc. position peaked at $1.05M in Q4 2015.
86 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2016.

Based on Brave Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.